Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial
BRITISH JOURNAL OF HAEMATOLOGY（2022）
关键词
multiple myeloma, autologous stem cell transplantation, high dose therapy, myeloma therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要